X0202 SCHEDULE 13G/A 0002068530 XXXXXXXX LIVE 1 Common Stock, par value $0.00001 per share 07/23/2026 0001191070 Neuphoria Therapeutics Inc. 64136E102 100 Summit Drive Burlington MA 01803 Rule 13d-1(b) Rule 13d-1(c) Coastlands Capital LP b DE 0.00 228594.00 0.00 228594.00 228594.00 N 4.23 IA PN The calculation of the beneficial ownership of the Reporting Persons is based on 5,404,551 shares of Common Stock issued and outstanding as of May 14, 2026, as reported by the Issuer in its Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on May 15, 2026. This Amendment No. 1 constitutes an exit filing for the Reporting Persons, as the Reporting Persons no longer beneficially own more than 5 percent of any class of securities of the Issuer. Coastlands Capital Partners LP b DE 0.00 228594.00 0.00 228594.00 228594.00 N 4.23 PN The calculation of the beneficial ownership of the Reporting Persons is based on 5,404,551 shares of Common Stock issued and outstanding as of May 14, 2026, as reported by the Issuer in its Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on May 15, 2026. This Amendment No. 1 constitutes an exit filing for the Reporting Persons, as the Reporting Persons no longer beneficially own more than 5 percent of any class of securities of the Issuer. Coastlands Capital GP LLC b DE 0.00 228594.00 0.00 228594.00 228594.00 N 4.23 OO The calculation of the beneficial ownership of the Reporting Persons is based on 5,404,551 shares of Common Stock issued and outstanding as of May 14, 2026, as reported by the Issuer in its Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on May 15, 2026. This Amendment No. 1 constitutes an exit filing for the Reporting Persons, as the Reporting Persons no longer beneficially own more than 5 percent of any class of securities of the Issuer. Coastlands Capital LLC b DE 0.00 228594.00 0.00 228594.00 228594.00 N 4.23 HC OO The calculation of the beneficial ownership of the Reporting Persons is based on 5,404,551 shares of Common Stock issued and outstanding as of May 14, 2026, as reported by the Issuer in its Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on May 15, 2026. This Amendment No. 1 constitutes an exit filing for the Reporting Persons, as the Reporting Persons no longer beneficially own more than 5 percent of any class of securities of the Issuer. Matthew D. Perry b X1 0.00 228594.00 0.00 228594.00 228594.00 N 4.23 HC IN The calculation of the beneficial ownership of the Reporting Persons is based on 5,404,551 shares of Common Stock issued and outstanding as of May 14, 2026, as reported by the Issuer in its Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on May 15, 2026. This Amendment No. 1 constitutes an exit filing for the Reporting Persons, as the Reporting Persons no longer beneficially own more than 5 percent of any class of securities of the Issuer. Neuphoria Therapeutics Inc. 100 Summit Drive Burlington, MA, 01803 Coastlands Capital LP, a Delaware limited partnership ("Coastlands") Coastlands Capital Partners LP, a Delaware limited partnership (the "Partnership") Coastlands Capital GP LLC, a Delaware limited liability company (the "General Partner") Coastlands Capital LLC, a Delaware limited liability company ("Coastlands GP") Matthew D. Perry Coastlands and the General Partner are the investment adviser and general partner, respectively, of the Partnership. Coastlands GP is the general partner of Coastlands. Mr. Perry is the control person of Coastlands, the Partnership, Coastlands GP and the General Partner. The reporting persons are filing this Schedule 13G jointly, but not as members of a group, and each disclaims membership in a group. Each reporting person also disclaims beneficial ownership of Common Stock except to the extent of that person's pecuniary interest therein. In addition, the filing of this Schedule 13G on behalf of the Partnership should not be construed as an admission that it is, and it disclaims that it is, a beneficial owner, as defined in Rule 13d-3 under the Act, of any Common Stock covered by this Schedule 13G. 601 California Street, Suite 1210, San Francisco, CA 94108 See Item 4 of the cover sheet for each reporting person. N IA HC Coastlands: 228,594 Partnership: 228,594 General Partner: 228,594 Coastlands GP: 228,594 Matthew D. Perry: 228,594 Coastlands: 4.23% Partnership: 4.23% General Partner: 4.23% Coastlands GP: 4.23% Matthew D. Perry: 4.23% Coastlands: 0 Partnership: 0 General Partner: 0 Coastlands GP: 0 Matthew D. Perry: 0 Coastlands: 228,594 Partnership: 228,594 General Partner: 228,594 Coastlands GP: 228,594 Matthew D. Perry: 228,594 Coastlands: 0 Partnership: 0 General Partner: 0 Coastlands GP: 0 Matthew D. Perry: 0 Coastlands: 228,594 Partnership: 228,594 General Partner: 228,594 Coastlands GP: 228,594 Matthew D. Perry: 228,594 N Y Y Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11. Coastlands Capital LP /s/ Mark Shamia 07/28/2026 Coastlands Capital Partners LP /s/ Mark Shamia 07/28/2026 Coastlands Capital GP LLC /s/ Mark Shamia 07/28/2026 Coastlands Capital LLC /s/ Mark Shamia 07/28/2026 Matthew D. Perry /s/ Matthew D. Perry 07/28/2026